Polimorfismo de los antígenos leucocitarios humanos en receptores cubanos de trasplante relacionado de progenitores hematopoyéticas

Burón Hernández, Jesús Salím; de la Guardia Peña, Odalis M; Chang Monteagudo, Arturo; Morera Barrios, Luz M; García García, María de los Á; Ustariz García, Catalino.
Rev. cuba. hematol. inmunol. hemoter ; 35(4): e1086, oct.-dic. 2019. tab
Artículo en Español | LILACS, CUMED | ID: biblio-1093294

Documentos relacionados

  1. In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
  2. The human leukocyte antigen as a candidate tumor suppressor.
  3. Susceptible and protective HLA-DR and HLA-DQ alleles for Fy<sup>a</sup> alloimmunization in the Croatian population.
  4. Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.
  5. HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic Leukemia.
  6. Prolongation of porcine islet xenograft survival in mice after therapy with immunosuppressive peptides.
  7. C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections.
  8. [Specific active immunotherapy of murine methylcholanthrene-induced sarcoma using a partially purified soluble tumor specific transplantation antigens].
  9. The use of peptide-major-histocompatibility-complex multimers in type 1 diabetes mellitus.
  10. The polymorphism of HLA-A, -C, -B, -DRB3/4/5, -DRB1, -DQB1 loci in Zhejiang Han population, China using NGS technology.